All Tissue/Cell Product Firms Must Register With CBER Under Proposed Rule
Executive Summary
All manufacturers of human cellular and tissue-based products would be required to register their products with the Center for Biologics Evaluation & Research, FDA said in a proposed rule published in the May 14 Federal Register.